About BioLayers SI
BioLayers SI started in Tashkent in 2026. Its founder read more than a hundred cancer papers and kept losing track of which mechanism came from which study, so he built the tool he was missing: one that keeps every claim tied to its source.
The people building BioLayers
Our founder and co-founders, with the engineers, data analysts and communicators who build alongside them.
Azizbek Gayratov
FounderLead Engineer
LinkedIn: Azizbek GayratovMuhammad Najmiddinov
Co-FounderMachine Learning Engineer
LinkedIn: Muhammad NajmiddinovBilolbek Yuldoshkhujayev
Lead Software Engineer
LinkedIn: Bilolbek YuldoshkhujayevAsliddin Abdurakhimov
Data Science & Machine Learning Engineer
LinkedIn: Asliddin AbdurakhimovOrzugul Mukhtorova
Data Analytics Specialist
LinkedIn: Orzugul MukhtorovaMaksat Babageldiyev
Machine Learning Engineer
LinkedIn: Maksat BabageldiyevMirkomil Nozimkhojiyev
Social Media & Community Lead
LinkedIn: Mirkomil Nozimkhojiyev
Scientific mentors
Physician-scientists and computational biologists who review our direction and our claims. Their guidance is personal: institutions are named for context and do not endorse BioLayers SI.
John-William Sidhom, MD, PhD
Physician-scientist in medical oncology, Weill Cornell Medicine and NewYork-Presbyterian
Grounds BioLayers in clinically meaningful oncology workflows, multi-omics genomics and translational evidence.
MD and PhD, Johns HopkinsLinkedIn: John-William Sidhom, MD, PhDEric E. Gardner, PhD
Assistant Professor, Thoracic/Head and Neck Medical Oncology, MD Anderson; James P. Allison Institute
Cancer plasticity, airway damage and new therapeutic targets in lung cancer.
PhD, Johns HopkinsLinkedIn: Eric E. Gardner, PhDJohn Paul Shen, MD
Assistant Professor, Gastrointestinal Medical Oncology, MD Anderson; CPRIT Scholar
Cancer genomics, CRISPR screens, synthetic lethality and machine-learning biomarkers in GI cancers.
PhD and fellowship, UC San DiegoLinkedIn: John Paul Shen, MDKathleen M. Schieffer, PhD
Assistant Professor, Nationwide Children's Hospital and The Ohio State University
Pediatric tumour genomics and turning sequencing into clinical precision oncology.
PhD, Penn State College of MedicineLinkedIn: Kathleen M. Schieffer, PhDBailey Glen, PhD
Senior Bioinformatics Scientist and Director, Hollings Cancer Center, MUSC
Sequencing informatics, multi-omics architecture and reproducible pipelines.
PhD, Clemson UniversityLinkedIn: Bailey Glen, PhD
We also work with partner organisations. See our partners
Privacy
When you create an account we store your email, name and avatar from your sign-in provider. For each mind map you save we store the map and the file name. We do not keep the text of the paper you uploaded.
Saved mind maps are public. Every map you save appears in the Library, where anyone can read it. There is no private option yet, so only map papers you are allowed to share. You can delete a saved map at any time from Settings.
Your Gemini API key is encrypted with AES-256-GCM before it is stored, and it is used only to send your requests to Google Gemini. Those requests are covered by Google’s terms. You can remove the key from Settings.
We measure page visits with Vercel Analytics and Speed Insights. To delete your account and everything attached to it, email biolayers.ai@gmail.com.
Terms
BioLayers SI is for research and education. It is not a medical device and must not be used to diagnose or treat anyone.
Mind maps are generated by a language model and can be wrong. Each statement links to the sentence it came from: check it there before you rely on it.
Atlas images keep the licence of the dataset they come from, shown on every record. Some are for non-commercial research only.
Only upload papers you have the right to use. Anything you save is published to the Library under your name.











